Market Overview

Congressman Tom Suozzi to Spotlight Scientific and Economic Development Advancements in New York

Share:

Congressman Tom Suozzi will join leaders of New York's biotechnology
community for a tour of Alexandria LaunchLabs.

The group will discuss prospects for, and impediments to, the continued
growth of this important New York industry.1 The
Congressman also will discuss how federal biotech policy and budget
debates could impact biomedical innovation.

WHAT:

    Tour and Q&A at Alexandria LaunchLabs
 

WHO:

Congressman Tom Suozzi

Ron Cohen, CEO, Acorda Therapeutics

Jim Greenwood, President & CEO, BIO

Jennifer Bland, CEO, NewYorkBIO

Other members of the New York bioscience community

 

WHEN:

Monday, July 30, 2018 at 11:00 am
 

WHERE:

Alexandria LaunchLabs
430 East 29th Street
14th Floor
New York City, NY

Media requested to RSVP to George Goodno, ggoodno@bio.org

1 https://www.bio.org/sites/default/files/NY-BIO2018%20-%20state%20profile.pdf

About Alexandria LaunchLabs

Alexandria LaunchLabs is the premier, full-service startup platform
designed to dramatically accelerate the growth of early-stage life
science startups. With its flagship site at the Alexandria Center®
for Life Science – New York City and its Cambridge site at the
Alexandria Center® at One Kendall Square, Alexandria
LaunchLabs provides move-in ready office/laboratory space, first-class
support resources, shared equipment and services, creative amenities and
access to startup capital through the Alexandria Seed Capital Platform—
all of which are critical for driving the growth of seed- and
early-stage companies across the country. The Alexandria LaunchLabs team
is currently accepting applications for future members in New York City
and Cambridge. For more information or to apply, please visit www.alexandrialaunchlabs.com.

About BIO

BIO is the world's largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world's largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO's blog chronicling "innovations transforming our world" and the
BIO Newsletter is the organization's bi-weekly email newsletter. Subscribe
to the BIO Newsletter
.

View Comments and Join the Discussion!